Concept-to-IND-Ready

SMALL MOLECULE Drug discovery

 

TURN-KEY-Integrated Model

Specializing in Target-to-IND stage projects that require one of the following: 
 

  • Create fresh NCE IP

  • 100% small molecule expertise

  • Create and expand discovery pipelines and IP portfolios

  • Custom / challenging chemistry, proteomics and in vitro assays

  • Turn-key support on program build-outs, fundraising, monetization and drug development

turn key 2.png

R&D Services

D_2png.png
  • Custom and challenging Science solutions

  • State of the Art Facilities, Instrumentation and Software

  • 70% PhD

Agile Integrated Programs

  • Teams under one roof

  • Rapid insights

  • Create IP

Proprietary Cascades

  • Covalent Inhibitor Programs

  • Protein degraders

  • Cannabinoid

  • Controlled substances

  • Novel modalities

IND-Enabling

IND enabling.png
  • Development candidate to IND

  • End-to-end project management & consulting

  • Expert CMC & toxicologist

Background.png

Beyond R&D

Icon_D-01.png
Consulting & Advisory
Icon_D-02.png
Intellectual Property
Icon_D-03.png
Fundraising
Icon_D-04.png
Monetizing